Skip to content
Wenlo
Sign in
← Markets

Marex Group plc

Paolo Tonucci (See Remarks) sells MRX shares

4MRXFiled Nov 12, 2026, 11:05 AM ET· Period Nov 9, 2026

About this filing

Marex Group plc (MRX) filed Form 4 (insider transaction) with the SEC on Nov 12, 2026. Form 4 reports a company insider’s trades in the company’s shares.

Key facts

Insider
Paolo Tonucci · See Remarks

Rule 10b5-1 plan

DateTransactionSharesPriceValueHeld afterOwnership
Nov 9, 2026S · open-market saleFootnotes F1, F2−3,196$67.89$216,980.911,249,709Direct
Nov 9, 2026S · open-market saleFootnotes F1, F3−10,760$68.74$739,595.061,238,949Direct
Nov 9, 2026S · open-market saleFootnotes F1, F4, F5−2,712$69.41$188,228.531,236,237Direct
Footnotes
  1. F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 plan entered into by the Reporting Person on October 22, 2025.
  2. F2 The price reported in Column 4 is a weighted average price. These shares were sold in transactions at prices ranging from $67.175 to $68.1625, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  3. F3 The price reported in Column 4 is a weighted average price. These shares were sold in transactions at prices ranging from $68.1775 to $69.1725, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  4. F4 The price reported in Column 4 is a weighted average price. These shares were sold in transactions at prices ranging from $69.175 to $69.885, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  5. F5 The number of ordinary shares reported herein includes 220,746 shares underlying unvested deferred bonus plan awards previously granted to the Reporting Person. Each award represents a contingent right to receive one (1) ordinary share of the Issuer upon vesting and settlement of the applicable award.

Remarks: Chief Strategist and CEO, Capital Markets

More MRX filings

Not investment advice. Summaries can contain errors; the SEC filing is the official record.